Consequences of rheumatoid arthritis for performance of social roles - A literature review

Journal of Rheumatology

Volumn 34, Issue 6, 2007, Pages 1248-1260

  Geuskens, Goedele A ^a   Burdorf, Alex ^a   Hazes, Johanna M W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Employment; International classification of functioning, disability and health; Participation; Rheumatoid arthritis; Social roles

Indexed keywords

ADULT; AGED; ARTICLE; EMPLOYMENT; EUROPE; HUMAN; LEISURE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECREATION; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SOCIAL ASPECT;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MIDDLE AGED; ROLE; SEX CHARACTERISTICS; SOCIAL IDENTIFICATION;

EID: 34250221186     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (77)

1. Scott DL, Smith C, Kingsley G. Joint damage and disability in rheumatoid arthritis: an updated systematic review. Clin Exp Rheumatol 2003;21 Suppl 31:S20-7.
2. Carr A, Hewlett S, Hughes R, et al. Rheumatology outcomes: the patient's perspective. J Rheumatol 2003;30:880-3.
3. Verstappen SM, Bijlsma JW, Verkleij H, et al. Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys. Arthritis Rheum 2004;51:488-97.
4. International Classification of Functioning, Disability and Health: ICF. Geneva: World Health Organization; 2001.
5. Jette AM, Haley SM, Kooyoomjian JT. Are the ICF activity and participation dimensions distinct? J Rehabil Med 2003;35:145-9.
6. Cieza A, Stucki G. Understanding functioning, disability, and health in rheumatoid arthritis: the basis for rehabilitation care. Curr Opin Rheumatol 2005;17:183-9.
7. Puolakka K, Kautiainen H, Mottonen T, et al. Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial. Arthritis Rheum 2005;52:36-41.
8. Stucki G, Cieza A, Geyh S, et al. ICF Core Sets for rheumatoid arthritis. J Rehabil Med 2004;44 Suppl:87-93.
9. Weigl M, Cieza A, Andersen C, Kollerits B, Amann E, Stucki G. Identification of relevant ICF categories in patients with chronic health conditions: a Delphi exercise. J Rehabil Med 2004;44 Suppl:12-21.
10. Brockow T, Cieza A, Kuhlow H, et al. Identifying the concepts contained in outcome measures of clinical trials on musculoskeletal disorders and chronic widespread pain using the International Classification of Functioning, Disability and Health as a reference. J Rehabil Med 2004;44 Suppl:30-6.
11. Ewert T, Fuessl M, Cieza A, et al. Identification of the most common patient problems in patients with chronic conditions using the ICF checklist. J Rehabil Med 2004;44 Suppl:22-9.
12. Stucki G, Cieza A. The International Classification of Functioning, Disability and Health Core Sets for rheumatoid arthritis: a way to specify functioning. Ann Rheum Dis 2004;63 Suppl 2:ii40-ii45.
13. Perenboom RJ, Chorus AM. Measuring participation according to the International Classification of Functioning, Disability and Health. Disabil Rehabil 2003;25:577-87.
14. Cieza A, Brockow T, Ewert T, et al. Linking health-status measurements to the International Classification of Functioning, Disability and Health. J Rehabil Med 2002;34:205-10.
15. Mottonen T, Hannonen P, Leirisalo-Repo M, et al. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo Trial Group. Lancet 1999;353:1568-73.
16. Combe B, Landewe R, Lukas C, et al. EULAR evidence based recommendations for the management of early rheumatoid arthritis [abstract]. Ann Rheum Dis 2005;64 Suppl 111:S212.
17. Albers JM, Kuper HH, van Riel PL, et al. Socio-economic consequences of rheumatoid arthritis in the first years of the disease. Rheumatology Oxford 1999;38:423-30.
18. Barrett EM, Scott DG, Wiles NJ, Symmons DP. The impact of rheumatoid arthritis on employment status in the early years of disease: a UK community-based study. Rheumatology Oxford 2000;39:1403-9.
19. Birnbaum HG, Barton M, Greenberg PE, et al. Direct and indirect costs of rheumatoid arthritis to an employer. J Occup Environ Med 2000;42:588-96.
20. Birrell FN, Hassell AB, Jones PW, Dawes PT. How does the Short Form 36 Health Questionnaire (SF-36) in rheumatoid arthritis (RA) relate to RA outcome measures and SF-36 population values? A cross-sectional study. Clin Rheumatol 2000;19:195-9.
21. Chorus AM, Miedema HS, Wevers CJ, van der Linden S. Labour force participation among patients with rheumatoid arthritis. Ann Rheum Dis 2000;59:549-54.
22. Dadoniene J, Stropuviene S, Venalis A, Boonen A. High work disability rate among rheumatoid arthritis patients in Lithuania. Arthritis Rheum 2004;51:433-9.
23. das Chagas Medeiros MM, Ferraz MB, Quaresma MR. The effect of rheumatoid arthritis on the quality of life of primary caregivers. J Rheumatol 2000;27:76-83.
24. Evers AWM, Kraaimaat FW, van Riel PLCM, de Jong AJL. Tailored cognitive-behavioral therapy in early rheumatoid arthritis for patients at risk: a randomized controlled trial. Pain 2002;100:141-53.
25. Ferguson SJ, Cotton S. Broken sleep, pain, disability, social activity, and depression symptoms in rheumatoid arthritis. Aust J Psychol 1996;48:9-14.
26. Fex E, Larsson BM, Nived K, Eberhardt K. Effect of rheumatoid arthritis on work status and social and leisure time activities in patients followed 8 years from onset. J Rheumatol 1998;25:44-50.
27. Fyrand L, Mourn T, Wichstrom L, Finset A, Glennas A. Social network size of female patients with rheumatoid arthritis compared to healthy controls. Scand J Rheumatol 2000;29:38-43.
28. Fyrand L, Moum T, Finset A, Glennas A. The effect of social network intervention for women with rheumatoid arthritis. Fam Proc 2003;42:71-89.
29. Hakkinen A, Sokka T, Lietsalmi AM, Kautiainen H, Hannonen P. Effects of dynamic strength training on physical function, Valpar 9 work sample test, and working capacity in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 2003;49:71-7.
30. Hallert E, Husberg M, Jonsson D, Skogh T. Rheumatoid arthritis is already expensive during the first year of the disease (the Swedish TIRA Project). Rheumatology Oxford 2004;43:1374-82.
31. Harwood RH, Carr AJ, Thompson PW, Ebrahim S. Handicap in inflammatory arthritis. Br J Rheumatol 1996;35:891-7.
32. Jantti J, Aho K, Kaarela K, Kautiainen H. Work disability in an inception cohort of patients with seropositive rheumatoid arthritis: a 20 year study. Rheumatology Oxford 1999;38:1138-41.
33. Katz PP. The impact of rheumatoid arthritis on life activities. Arthritis Care Res 1995;8:272-8.
34. Kobelt G, Eberhardt K, Geborek P. TNF inhibitors in the treatment of rheumatoid arthritis in clinical practice: costs and outcomes in a follow up study of patients with RA treated with etanercept or infliximab in southern Sweden. Ann Rheum Dis 2004;63:4-10.
35. Korthals-de Bos I, Van Tulder M, Boers M, et al. Indirect and total costs of early rheumatoid arthritis: a randomized comparison of combined step-down prednisolone, methotrexate, and sulfasalazine with sulfasalazine alone. J Rheumatol 2004;31:1709-16.
36. Lapsley HM, March LM, Tribe KL, Cross MJ, Courtenay BG, Brooks PM. Living with rheumatoid arthritis: expenditures, health status, and social impact on patients. Ann Rheum Dis 2002;61:818-21.
37. Lerner D, Adler DA, Chang H, et al. Unemployment, job retention, and productivity loss among employees with depression. Psychiatr Serv 2004;55:1371-8.
38. Lindroth Y, Brattstrom M, Bellman I, et al. A problem-based education program for patients with rheumatoid arthritis: evaluation after three and twelve months. Arthritis Care Res 1997;10:325-32.
39. MacKinnon JR, Miller WC. Rheumatic arthritis and self esteem: the impact of quality occupation. J Occup Science 2003;10:90-8.
40. Mau W, Bornmann M, Weber H, Weidemann HF, Hecker H, Raspe HH. Prediction of permanent work disability in a follow-up study of early rheumatoid arthritis: results of a tree structured analysis using RECPAM. Br J Rheumatol 1996;35:652-9.
41. Merkesdal S, Ruof J, Schoffski O, Bernitt K, Zeidler H, Mau W. Indirect medical costs in early rheumatoid arthritis: composition of and changes in indirect costs within the first three years of disease. Arthritis Rheum 2001;44:528-34.
42. Nordstrom DC, Konttinen YT. Solovieva S, Friman C, Santavirta S. In- and out-patient rehabilitation in rheumatoid arthritis. A controlled, open, longitudinal, cost-effectiveness study. Scand J Rheumatol 1996;25:200-6.
43. Puolakka K, Kautiainen H, Mottonen T, et al. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial. Arthritis Rheum 2004;50:55-62.
44. Reisine S, Fifield J, Walsh SJ, Feinn R. Factors associated with continued employment among patients with rheumatoid arthritis: a survival model. J Rheumatol 2001;28:2400-8.
45. Reisine S, Fifield J, Winkelman DK. Employment patterns and their effect on health outcomes among women with rheumatoid arthritis followed for 7 years. J Rheumatol 1998;25:1908-16.
46. Riemsma RP, Taal E, Rasker JJ, Houtman PM, Van Paassen HC, Wiegman O. Evaluation of a Dutch version of the AIMS2 for patients with rheumatoid arthritis. Br J Rheumatol 1996;35:755-60.
47. Ruof J, Hulsemann JL, Mittendorf T, et al. Costs of rheumatoid arthritis in Germany: a micro-costing approach based on healthcare payer's data sources. Ann Rheum Dis 2003;62:544-9.
48. Siu AM, Chui DY. Evaluation of a community rehabilitation service for people with rheumatoid arthritis. Patient Educ Couns 2004;55:62-9.
49. Soderlin MK, Nieminen P, Hakala M. Arthritis Impact Measurement Scales in a community-based rheumatoid arthritis population. Clin Rheumatol 2000;19:30-4.
50. Sokka T, Kautiainen H, Mottonen T, Hannonen P. Work disability in rheumatoid arthritis 10 years after the diagnosis. J Rheumatol 1999;26:1681-5.
51. Stavem K, Lossius MI, Kvien TK, Guldvog B. The health-related quality of life of patients with epilepsy compared with angina pectoris, rheumatoid arthritis, asthma and chronic obstructive pulmonary disease. Qual Life Res 2000;9:865-71.
52. Straaton KV, Maisiak R, Wrigley JM, White MB, Johnson P, Fine PR. Barriers to return to work among persons unemployed due to arthritis and musculoskeletal disorders. Arthritis Rheum 1996;39:101-9.
53. Strand V, Tugwell P, Bombardier C, et al. Function and health-related quality of life: results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group. Arthritis Rheum 1999;42:1870-8.
54. Turner Cobb JM, Steptoe A, Perry L, Axford J. Adjustment in patients with rheumatoid arthritis and their children. J Rheumatol 1998;25:565-71.
55. van Jaarsveld CH, Jacobs JW, Schrijvers AJ, van Albada-Kuipers GA, Hofman DM, Bijlsma JW. Effects of rheumatoid arthritis on employment and social participation during the first years of disease in The Netherlands. Br J Rheumatol 1998;37:848-53.
56. van Lankveld W, van Helmond T, Naring G, de Rooij DJ, van den Hoogen F. Partner participation in cognitive-behavioral self-management group treatment for patients with rheumatoid arthritis. J Rheumatol 2004;31:1738-45.
57. Verstappen SM, Boonen A, Bijlsma JW, et al. Working status among Dutch patients with rheumatoid arthritis: work disability and working conditions. Rheumatology Oxford 2005;44:202-6.
58. Vlak T, Eldar R. Disability in rheumatoid arthritis after monotherapy with DMARDs. Int J Rehabil Res 2003;26:207-12.
59. Walsh JD, Blanchard EB, Kremer JM, Blanchard CG. The psychosocial effects of rheumatoid arthritis on the patient and the well partner. Behav Res Ther 1999;37:259-71.
60. Wiles NJ, Scott DG, Barrett EM, et al. Benchmarking: the five year outcome of rheumatoid arthritis assessed using a pain score, the Health Assessment Questionnaire, and the Short Form-36 (SF-36) in a community and a clinic based sample. Ann Rheum Dis 2001;60:956-61.
61. Williamson D, Robinson ME, Melamed B. Pain behavior, spouse responsiveness, and marital satisfaction in patients with rheumatoid arthritis. Behav Modif 1997;21:97-118.
62. Wolfe F, Hawley DJ. The longterm outcomes of rheumatoid arthritis: Work disability: a prospective 18 year study of 823 patients. J Rheumatol 1998;25:2108-17.
63. Young A, Dixey J, Kulinskaya E, et al. Which patients stop working because of rheumatoid arthritis? Results of five years' follow up in 732 patients from the Early RA Study (ERAS). Ann Rheum Dis 2002;61:335-40.
64. Zhao SZ, Fiechtner JI, Tindall EA, et al. Evaluation of health-related quality of life of rheumatoid arthritis patients treated with celecoxib. Arthritis Care Res 2000;13:112-21.
65. Zink A, Braun J, Listing J, Wollenhaupt J. Disability and handicap in rheumatoid arthritis and ankylosing spondylitis - results from the German rheumatological database. German Collaborative Arthritis Centers. J Rheumatol 2000;27:613-22.
66. Zink A, Listing J, Klindworth C, Zeidler H. The national database of the German Collaborative Arthritis Centres: 1. Structure, aims, and patients. Ann Rheum Dis 2001;60:199-206.
67. Reisine S, McQuillan J, Fifield J. Predictors of work disability in rheumatoid arthritis patients. A five-year followup. Arthritis Rheum 1995;38:1630-7.
68. Scott DL. Leflunomide improves quality of life in rheumatoid arthritis. Scand J Rheumatol Suppl 1999;112:23-9.
69. Ahlmen M, Nordenskiold U, Archenholtz B, et al. Rheumatology outcomes: the patient's perspective. A multicentre focus group interview study of Swedish rheumatoid arthritis patients. Rheumatology Oxford 2005;44:105-10.
70. Mancuso CA, Paget SA, Charlson ME. Adaptations made by rheumatoid arthritis patients to continue working: a pilot study of workplace challenges and successful adaptations. Arthritis Care Res 2000;13:89-99.
71. Hazes JMW, Geuskens GA, Burdorf A. Work limitations in the outcome assessment of rheumatoid arthritis [editorial]. J Rheumatol 2005;32:980-2.
72. Chung C, Sokka T, Arbogast P, Pincus T. Work disability in early rheumatoid arthritis: differences across two systems in the US and Finland [abstract]. Ann Rheum Dis 2005;64 Suppl 111:S71.
73. Boonen A, van der Heijde D, Landewe R, et al. Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries. Ann Rheum Dis 2002;61:429-37.
74. Verhoeven AC, Boers M, van der Linden S. Validity of the MACTAR questionnaire as a functional index in a rheumatoid arthritis clinical trial. J Rheumatol 2000;27:2801-9.
75. Katz PP, Yelin EH. Activity loss and the onset of depressive symptoms: do some activities matter more than others? Arthritis Rheum 2001;44:1194-202.
76. Westhovens R, Rahman MU, Han C, Bala M, Han J, Yocum D. Infliximab treatment results in a rapid improvement in all aspects of quality of life assessed by the SF-36 in patients with rheumatoid arthritis: results from the START trial [abstract]. Ann Rheum Dis 2005;64 Suppl 111:S392.
77. Goekoop-Ruiterman YPM, de Vries-Bouwstra JK, Allaart CF, et al. Clinical and radiological outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled study. Arthritis Rheum 2005;52:3381-90.